| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.009 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |